{
    "attributes": {
        "action": "Kalydeco (ivacaftor) to be funded for under 6's, by NHS England",
        "additional_details": "The treatment is eligible for 9 different rare genotypes and currently funded for ages 2-5, on the NHS in Scotland. At the moment it is only funded in England For those over six years old. Kalydeco has been proven to treat the underlying cause of cystic fibrosis in those 9 gene mutations, to significantly increase lung function, slow the progression of cystic fibrosis and halve hospital admissions.\r\n\r\nPlease help William and other children effected by cystic fibrosis by signing this petition\r\n\r\n",
        "background": "Currently Kalydeco is funded by the NHS for children with a rarer types of Cystic fibrosis from age 6 years and over.\r\nVertex has recently liscenced the drugs from the age of 2 years. However the NHS has yet to decide whether to agree funding.\r\nThis medication is considered life changing",
        "closed_at": null,
        "created_at": "2016-11-11T17:08:05.361Z",
        "creator_name": "Emma Foord ",
        "debate": null,
        "debate_outcome_at": null,
        "debate_threshold_reached_at": null,
        "government_response": null,
        "government_response_at": null,
        "moderation_threshold_reached_at": "2016-11-11T17:33:00.878Z",
        "open_at": "2016-11-17T17:48:10.081Z",
        "rejected_at": null,
        "rejection": null,
        "response_threshold_reached_at": null,
        "scheduled_debate_date": null,
        "signature_count": 640,
        "state": "open",
        "updated_at": "2017-04-06T03:13:34.035Z"
    },
    "id": 172240,
    "links": {
        "self": "https://petition.parliament.uk/petitions/172240.json"
    },
    "type": "petition"
}